DexCom Inc (DXCM) income statement
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value
$82.52+0.48 (+0.59%)
Close on Nov 18, 2026Market cap $30.78BP/E 32.5Yield –
DexCom Inc income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 63.4%
- Operating margin
- 24.0%
- Net margin
- 19.4%
- Return on equity, FY2025
- 34.5%
Financial strength
- Current ratio
- 1.74
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 42.7%
Valuation
- P/E ratio
- 32.5
- Price to sales
- 6.03
- Price to book
- 12.14
- Dividend yield
- –
See a number that looks wrong?